UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.

their product pipeline is filled with their new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, Autoimmune diseases, and Allergy, along with a portfolio of Animal health diseases. These products are based on their proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies.